Cite
MLA Citation
Timothy J Straub et al.. “LB15. SER-109, an Investigational Microbiome Therapeutic, Reduces Abundance of Antimicrobial Resistance Genes in Patients with Recurrent Clostridioides difficile Infection (rCDI) after Standard-of-Care Antibiotics.” Open forum infectious diseases, vol. 8, n.d., pp. S812–S813. http://access.bl.uk/ark:/81055/vdc_100150542630.0x000027